GATC Biotech is the no. 1 sequencing service provider in Europe. This success is based on GATC Biotech’s commitment to pioneer innovative services:
1990 - GATC Biotech is Europe’s first sequencing company
1992 - World's first non-radioactive sequencing technology invented by GATC Biotech
1997 - World's first 24h sequencing service
1998 – World´s first online Life Science Internet Ordering and Delivery System
2006 - World's first multiplatform sequencing service provider with Illumina GA & Roche GS 20
2007 - World's first NightXpress service (honoured by the initiative "Germany - Land of Ideas")
2010 - World’s first commercial platform Illumina HiSeq 2000
2011 - Europe's first commercial platform PacBio RS
Our success in participating in internationally highly recognised research projects underlines our business strategy to invest early in innovative technologies. Here are some of our project highlights:
LifeCodexx AG, a German affiliate of GATC Biotech, offers clinically validated molecular diagnostic tests. The PraenaTest® was developed between 2009 and 2012 by LifeCodexx AG in collaboration with several leading prenatal centres in Germany and Switzerland and based on GATC Biotech’s expertise in Next Generation Sequencing.
Today, GATC Biotech successfully serves over 10,000 customers in 40 countries around the globe in industries and academia. GATC Biotech’s expertise and reliability feeds long-term customer relationships, for example with Research Council UK: